Skip to main content
Log in

GH response to hypoglycemia and clonidine in the GH-releasing hormone resistance syndrome

  • Original Articles
  • Published:
Journal of Endocrinological Investigation Aims and scope Submit manuscript

Abstract

GH secretion by the pituitary is the result of the balance between the stimulatory effect of GHRH and the inhibitory effect of SS. Patients with mutations in GHRH receptor (GHRH-R) gene (GHRH-R) offer a unique model to study the mechanism of action of different GH secretion stimuli. In the past, we have demonstrated a small but significant GH response to a GH secretagogue (GHRP-2) in a homogenous cohort of patients with severe GH deficiency (GHD) due to a homozygous null mutation in GHRH-R (IVS1+1G→A). Now, we sought to determine if we could detect a GH response to hypoglycemia (ITT: insulin tolerance test) or clonidine (CL) in these patients. Nine young GHD subjects underwent both ITT and CL tests, and 2 additional subjects underwent only CL test. There was a small but significant GH increase during ITT, but not during CL test. These results indicate that a minimal albeit significant GH response to ITT can occur despite complete lack of GHRH-R function.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Veldhuis JD, Bowers CY. Human GH pulsatility: an ensemble property regulated by age and gender. J Endocrinol Invest 2003, 26: 799–813.

    Article  PubMed  CAS  Google Scholar 

  2. Giustina A, Veldhuis JD. Pathophysiology of the neuroregulation of growth hormone secretion in experimental animals and the human. Endocr Rev 1998, 19: 717–97.

    PubMed  CAS  Google Scholar 

  3. Wortley KE, Anderson KD, Garcia K, et al. Genetic deletion of ghrelin does not decrease food intake but influences metabolic fuel preference. Proc Natl Acad Sci USA 2004, 101: 8227–32.

    Article  PubMed Central  PubMed  CAS  Google Scholar 

  4. Cordido F, Dieguez C, Casanueva FA. Effect of central cholinergic neurotransmission enhancement by pyridostigmine on the growth hormone secretion elicited by clonidine, arginine, or hypoglycemia in normal and obese subjects. J Clin Endocrinol Metab 1990, 70: 1361–70.

    Article  PubMed  CAS  Google Scholar 

  5. Murray RA, Maheshwari HG, Russell EJ, Baumann G. Pituitary hypoplasia in patients with a mutation in the growth hormone-releasing hormone receptor gene. AJNR Am J Neuradiol 2000, 21: 685–9.

    CAS  Google Scholar 

  6. Oliveira HA, Salvatori R, Krauss MP, Oliveira CR, Silva PR, Aguiar-Oliveira MH. Magnetic resonance imaging study of pituitary morphology in subjects homozygous and heterozygous for a null mutation of the GHRH receptor gene. Eur J Endocrinol 2003, 148: 427–32.

    Article  PubMed  CAS  Google Scholar 

  7. Roelfsema F, Biermasz NR, Veldman RG, et al. Growth hormone secretion in patients with an inactivating defect of the GH-releasing hormone (GHRH) receptor is pulsatile: evidence for a role for non-GHRH inputs into the generation of GH pulses. J Clin Endocrinol Metab 2001, 86: 2459–64.

    Article  PubMed  CAS  Google Scholar 

  8. Maheshwari HG, Pezzoli SS, Rahim A, Shalet SM, Thorner MO, Baumann G. Pulsatile growth hormone secretion persists in genetic growth hormone-releasing hormone resistance. Am J Physiol Endocrinol Metab 2002, 282: E943–51.

    PubMed  CAS  Google Scholar 

  9. Gondo RG, Aguiar-Oliveira MH, Hayashida CY, et al. Growth hormone-releasing peptide-2 stimulates GH secretion in GH-deficient patients with mutated GH-releasing hormone receptor. J Clin Endocrinol Metab 2001, 86: 3279–83.

    PubMed  CAS  Google Scholar 

  10. Salvatori R, Hayashida CY, Aguiar-Oliveira MH, et al. Familial dwarfism due to a novel mutation of the growth hormonereleasing hormone receptor gene. J Clin Endocrinol Metab 1999, 84: 917–23.

    PubMed  CAS  Google Scholar 

  11. Aguiar-Oliveira MH, Gill MS, Barreto ESA, et al. Effect of severe growth hormone (GH) deficiency due to a mutation in the GH-releasing hormone receptor on insulin-like growth factors (IGFs), IGF-binding proteins, and ternary complex formation throughout life. J Clin Endocrinol Metab 1999, 84: 4118–26.

    PubMed  CAS  Google Scholar 

  12. Hayashida CY, Gondo RG, Ferrari C, et al. Familial growth hormone deficiency with mutated GHRH receptor gene: clinical and hormonal findings in homozygous and heterozygous individuals from Itabaianinha-SE. Eur J Endocrinol 2000, 142: 557–63.

    Article  PubMed  CAS  Google Scholar 

  13. Diggle PJ, Liang KY, Zeger SL. Analysis of longitudinal data. Oxford: Clarendon. 1994, 146–67.

    Google Scholar 

  14. Strasburger CJ. Laboratory assessment of GH. Growth Horm IGF Res 1998, 8(Suppl A): 41–6.

    Article  PubMed  CAS  Google Scholar 

  15. Mullis PE. Genetic control of growth. Eur J Endocrinol 2005, 152: 11–31.

    Article  PubMed  CAS  Google Scholar 

  16. Alba M, Salvatori R. GHRH receptor mutations in isolated GH deficiency. The Endocrinologist 2003, 13: 422–7.

    Article  Google Scholar 

  17. Maheshwari HG, Silverman BL, Dupuis J, Baumann G. Phenotype and genetic analysis of a syndrome caused by an inactivating mutation in the growth hormone-releasing hormone receptor: Dwarfism of Sindh. J Clin Endocrinol Metab 1998, 83: 4065–74.

    PubMed  CAS  Google Scholar 

  18. Salvatori R, Fan X, Veldhuis JD, Couch R. Serum GH response to pharmacological stimuli and physical exercise in two new inactivating mutations in the GH-releasing hormone. Eur J Endocrinol 2002, 147: 591–6.

    Article  PubMed  CAS  Google Scholar 

  19. Frishmeyer PA, Dietz HC. Nonsense-mediated mRNA decay in health and disease. Hum Mol Genet 1999, 8: 1893–900.

    Article  Google Scholar 

  20. Fisher BM, Thornton S, Hepburn DA, et al. Effect of alphaadrenergic blockade on pituitary hormonal responses to insulin-induced hypoglycemia in humans. Acta Endocrinol (Copenh) 1991, 125: 372–7.

    CAS  Google Scholar 

  21. Darzy KH, Aimaretti G, Wieringa, Gattamaneni HR, Ghigo Shalet SM. The usefulness of the combined growth hormone (GH)-releasing hormone and arginine stimulation test in the diagnosis of radiation-induced GH deficiency is dependent on the post-irradiation time interval. J Clin Endocrinol Metab 2003, 88: 95–102.

    Article  PubMed  CAS  Google Scholar 

  22. Masuda A, Shibasaki T, Hotta M, et al. Insulin-induced hypoglycemia, L-dopa and arginine stimulate GH secretion through different mechanisms in man. Regul Pept 1990, 31: 53–64.

    Article  PubMed  CAS  Google Scholar 

  23. Hanew K, Tanaka A, Utsumi A, Sugawara A, Abe K. The inhibitory effects of growth hormone-releasing hormone (GHRH)-antagonist on GHRH, L-dopa, and clonidine-induced GH secretion in normal subjects. J Clin Endocrinol Metab 1996, 81: 1952–5.

    PubMed  CAS  Google Scholar 

  24. Gil-Ad I, Gurewitz R, Marcovici O, Rosenfeld J, Laron Z. Effect of aging on human plasma growth hormone response to clonidine. Mech Aging Dev 1984 27: 97–100.

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to R. Salvatori MD.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Salvatori, R., Serpa, M.G., Parmigiani, G. et al. GH response to hypoglycemia and clonidine in the GH-releasing hormone resistance syndrome. J Endocrinol Invest 29, 805–808 (2006). https://doi.org/10.1007/BF03347374

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF03347374

Key-words

Navigation